Ozone Application Before Fissure Sealants

Sponsor
IRCCS Burlo Garofolo (Other)
Overall Status
Recruiting
CT.gov ID
NCT04040920
Collaborator
(none)
67
1
2
30
2.2

Study Details

Study Description

Brief Summary

Decay is a multifactorial infective degenerative disease of hard dental tissues, caused by Streptococcus mutans and Lactobacillus forming the bacterial biofilm of teeth surfaces. Decays generally evolve in fissures and pits of secondary molars. Pits and fissure sealants prevent decays if performed in two years from eruption. Ozone has bactericidal effect and remineralizing capacity on enamel.

The aim of this study is to assess the effectiveness of ozone application before sealants in increasing their duration in time.

Condition or Disease Intervention/Treatment Phase
  • Device: Ozone
  • Other: Pits and fissure sealants
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
67 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Splith mouth designSplith mouth design
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effect of Ozone Application Before Fissure Sealants: a Split Mouth Randomized Controlled Trial
Actual Study Start Date :
Apr 1, 2021
Anticipated Primary Completion Date :
Sep 30, 2022
Anticipated Study Completion Date :
Sep 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ozone therapy

Ozone application before pits and fissure sealants

Device: Ozone
One minute of pretreatment with ozone by using the OzoneDTA device

Other: Pits and fissure sealants
cleansing of the occlusal surfaces with a nylon brush and polishing toothpaste; surface etching with 36% orthophosphoric acid for 30'', surface cleaning and drying for 30 '', application of the sealing material, polymerization for 60'';

Active Comparator: Pits and fissure sealants

Other: Pits and fissure sealants
cleansing of the occlusal surfaces with a nylon brush and polishing toothpaste; surface etching with 36% orthophosphoric acid for 30'', surface cleaning and drying for 30 '', application of the sealing material, polymerization for 60'';

Outcome Measures

Primary Outcome Measures

  1. Sealants failure [12 months after sealant]

    Frequency of sealed failure defined as presence of to one or more of these outcomes: Marginal fissure; Sealant fracture; Decay; Marginal pigmentations; Sealant detachment Evaluation of the relative frequency of the different causes of failure

Secondary Outcome Measures

  1. Sealants failure [6 months after sealant]

    Frequency of sealed failure defined as presence of to one or more of these outcomes: Marginal fissure; Sealant fracture; Decay; Marginal pigmentations; Sealant detachment Evaluation of the relative frequency of the different causes of failure

  2. Sealants failure [24 months after sealant]

    Frequency of sealed failure defined as presence of to one or more of these outcomes: Marginal fissure; Sealant fracture; Decay; Marginal pigmentations; Sealant detachment Evaluation of the relative frequency of the different causes of failure

  3. Secondary decay in failed sealants [6 months after sealant]

    Frequency of secondary decay in teeth with failed sealants

  4. Secondary decay in failed sealants [12 months after sealant]

    Frequency of secondary decay in teeth with failed sealants

  5. Secondary decay in failed sealants [24 months after sealant]

    Frequency of secondary decay in teeth with failed sealants

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 16 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • first or second secondary molars to be sealed

  • possibility to isolate with rubber dam both the teeth involved

  • no clear signs of pigmentations

  • good general health

Exclusion Criteria:
  • latex allergy

  • epilepsy or other severe neurological pathologies

  • psychiatric disease

  • excessive sensibility to electrical current

  • severe asthma

  • enamel disorders, such as amelogenesis imperfect, white spots, fluorosis or Molar Incisors Hypomineralization

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institute for Maternal and Child Health - IRCCS Burlo Garofolo- Trieste Italy 34137

Sponsors and Collaborators

  • IRCCS Burlo Garofolo

Investigators

  • Study Chair: Milena Cadenaro, DDS,MSc,PhD, IRCCS Burlo Garofolo
  • Principal Investigator: Maddalena Chermetz, DDS,MSc, IRCCS Burlo Garofolo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
IRCCS Burlo Garofolo
ClinicalTrials.gov Identifier:
NCT04040920
Other Study ID Numbers:
  • RC 02/2019
First Posted:
Aug 1, 2019
Last Update Posted:
Jan 6, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by IRCCS Burlo Garofolo
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 6, 2022